Terns Pharmaceuticals (TERN) PT Raised to $35 at Citizens: Becoming Best-in-Class
Tweet Send to a Friend
Citizens analyst Silvan Tuerkcan raised the price target on Terns Pharmaceuticals (NASDAQ: TERN) to $35.00 (from $25.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
